Aspect Biosystems

Cellink

This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.

Dimension Bio

This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.

Volumetric | 3D Systems

This company develops bioprinting technologies and vascularised human tissues for pharmaceutical researchers and medical institutions conducting drug testing and organ replacement research.

Hooke Bio

This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.

Allevi

This company develops 3D bioprinters and bioinks for researchers in tissue engineering, drug development and regenerative medicine.

Encellin

The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.

Endogenex

This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.